Evidence map›Paper›PMID 28856589›Full record

ArticleInfection2017

Impact of a mixed educational and semi-restrictive antimicrobial stewardship project in a large teaching hospital in Northern Italy.

Daniele Roberto Giacobbe, Valerio Del Bono, Malgorzata Mikulska, Giulia Gustinetti, Anna Marchese, Federica Mina, Alessio Signori, Andrea Orsi, Fulvio Rudello, Cristiano Alicino and 6 more

Erratum issuedAbstract read
PubMed Publisher
In one paragraph

Article in Infection, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Long-Term Carbapenems Antimicrobial Stewardship Program.Antibiotics (Basel, Switzerland) · 2020
    Article
  6. Article
  7. Article
  8. Reducing dissemination of carbapenem-resistantAnnals of translational medicine · 2019
    Article
  9. Article
  10. Article
  11. Meropenem antimicrobial stewardship program: clinical, economic, and antibiotic resistance impact.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2019
    Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. De-escalation and discontinuation strategies in high-risk neutropenic patients: an interrupted time series analyses of antimicrobial consumption and impact on outcome.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2018
    Article
  17. Review
  18. Article
  19. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

16 authors.

Daniele Roberto GiacobbeU.O. Clinica Malattie Infettive, University of Genoa (DISSAL) and Ospedale Policlinico San Martino-IRCCS per L'Oncologia, L.go R. Benzi, 10, 16132, Genoa, Italy. daniele.roberto.giacobbe@edu.unige.it.ORCID http://orcid.org/0000-0003-2385-1759
Valerio Del BonoU.O. Clinica Malattie Infettive, University of Genoa (DISSAL) and Ospedale Policlinico San Martino-IRCCS per L'Oncologia, L.go R. Benzi, 10, 16132, Genoa, Italy.
Malgorzata MikulskaU.O. Clinica Malattie Infettive, University of Genoa (DISSAL) and Ospedale Policlinico San Martino-IRCCS per L'Oncologia, L.go R. Benzi, 10, 16132, Genoa, Italy.
Giulia GustinettiU.O. Clinica Malattie Infettive, University of Genoa (DISSAL) and Ospedale Policlinico San Martino-IRCCS per L'Oncologia, L.go R. Benzi, 10, 16132, Genoa, Italy.
Anna MarcheseS.S.D. Microbiologia, University of Genoa (DISC) and Ospedale Policlinico San Martino-IRCCS per L'Oncologia, Genoa, Italy.
Federica MinaU.O. Farmacia, Ospedale Policlinico San Martino-IRCCS per l'Oncologia, Genoa, Italy.
Alessio SignoriUniversity of Genoa (DISSAL), Genoa, Italy.
Andrea OrsiU.O. Igiene, University of Genoa (DISSAL) and Ospedale Policlinico San Martino-IRCCS per l'Oncologia, Genoa, Italy.
Fulvio RudelloSANTALUCIA PHARMA APPS©, Località Gragnanino, Gragnano Trebbiense, PC, Italy.
Cristiano AlicinoU.O. Igiene, University of Genoa (DISSAL) and Ospedale Policlinico San Martino-IRCCS per l'Oncologia, Genoa, Italy.
Beatrice BonalumiU.O. Farmacia, Ospedale Policlinico San Martino-IRCCS per l'Oncologia, Genoa, Italy.
Alessandra MorandoU.O. Governo Clinico e Organizzazione Ospedaliera, Ospedale Policlinico San Martino-IRCCS per l'Oncologia, Genoa, Italy.
Giancarlo IcardiU.O. Igiene, University of Genoa (DISSAL) and Ospedale Policlinico San Martino-IRCCS per l'Oncologia, Genoa, Italy.
Sabrina BeltraminiU.O. Farmacia, Ospedale Policlinico San Martino-IRCCS per l'Oncologia, Genoa, Italy.
Claudio ViscoliU.O. Clinica Malattie Infettive, University of Genoa (DISSAL) and Ospedale Policlinico San Martino-IRCCS per L'Oncologia, L.go R. Benzi, 10, 16132, Genoa, Italy.
San Martino Antimicrobial Stewardship Group

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe overuse of antimicrobials favors the dissemination of antimicrobial resistance, as well as invasive fungal diseases and Clostridium difficile infections (CDI). In this study, we assessed the impact of a mixed educational and semi-restrictive antimicrobial stewardship (AMS) project in a large teaching hospital in Italy.

methodsThe AMS project was conducted from May 2014 to April 2016. It consisted of two initiatives in two consecutive periods: (1) educational activities; (2) semi-restrictive control of antimicrobial prescribing through a computerized software. The primary endpoint was consumption of antibacterials and antifungals. Secondary endpoints were incidence of CDI, methicillin-resistant Staphylococcus aureus (MRSA) bloodstream infections (BSI), carbapenem-resistant Klebsiella pneumoniae (CRKP) BSI, and Candida BSI.

resultsDuring the study period, a statistically significant reduction in consumption was observed for antibacterials (-1.45 defined daily doses (DDD)/1000 patient-days monthly, 95% confidence intervals [CI] -2.38 to -0.52, p 0.004), mainly driven by reductions in the use of fluoroquinolones, third/fourth generation cephalosporins, and carbapenems. No decrease in consumption of antifungals was observed (-0.04 DDD/1000 patient-days monthly, 95% CI -0.34 to +0.25, p 0.750). A statistically significant trend towards reduction was observed for incidence of CRKP BSI (incidence rate ratio 0.96, 95% CI 0.92-0.99, p 0.013). No statistically significant variations in trends were observed for CDI, MRSA BSI, and Candida BSI.

conclusionsThe mixed AMS project was effective in reducing the use of major antibacterials and the incidence of CRKP BSI. Further research is needed to assess the extent of long-term benefits of semi-restrictive approaches.

Indexed as

Anti-Bacterial AgentsAntifungal AgentsAntimicrobial StewardshipBacteremiaCandidiasisHospitals, TeachingIncidenceItalyAnti-Bacterial AgentsAntifungal AgentsAntibioticsAntifungalsAntimicrobial resistanceAntimicrobial stewardshipCarbapenemsCDIClostridiumCPECREDDDKlebsiellaKPC

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.